OpenAI

OpenAI is an American artificial intelligence research company best known for developing ChatGPT, the conversational AI assistant that brought generative AI into widespread public use. Founded originally as a nonprofit research lab, it later restructured into a capped-profit company and has grown into one of the most influential organizations in the global AI industry, backed by major investors including Microsoft.

The company's portfolio centers on large language models powering ChatGPT and a suite of APIs used by developers and enterprises worldwide. OpenAI has expanded well beyond text generation: it has launched a dedicated robotics division, opened a biodefense AI unit called Rosalind Biodefense, and is pursuing pharmaceutical partnerships — signaling ambitions that span multiple industries. The company is also preparing for an initial public offering, a landmark transition from its research-lab origins.

OpenAI's scale and rapid growth have attracted significant regulatory and legal scrutiny. A coalition of 42 state attorneys general has launched a formal investigation examining the company's data practices, user safety measures, and impacts on vulnerable groups, while lawsuits over alleged product harms have intensified public debate. These developments position OpenAI at the center of broader conversations about AI governance, corporate accountability, and the societal responsibilities that come with deploying AI at scale.